Acuta Capital Partners’s AN2 Therapeutics ANTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-132,000	Closed	-$2.7M	–	34
2023 Q4	$2.7M	Buy	132,000 +118,700	+892%	+$2.43M	1.52%	24
2023 Q3	$214K	Buy	+13,300	New	+$214K	0.14%	38